See article vol. 29: 1774-1790
In this issue, Kim et al. reported the effects of metabolic syndrome (MetS) and its components, including a body shape index (ABSI), on increased arterial stiffness measured using the cardio-ankle vascular index (CAVI) according to sex and age strata. They found that MetS diagnosed with ABSI instead of waist circumference (WC) was more significantly associated with the CAVI in all age–sex groups in Koreans1). This result is consistent with the studies in Japanese reported by Nagayama et.al 2) and Sugiura et.al.3). These results might give an important warning to the criteria of MetS used worldwide now.
MetS is proposed to be derived essentially from visceral adipose tissue4). Therefore, the criterion of obesity shape for MetS should have to adopt an index reflecting visceral adipose tissue mass. Originally, visceral fat area at the umbilicus level was presented as an index of visceral fat mass using abdominal CT imaging5), but it is not easy to take CT in daily clinical work and public health activities. Then, WC was adopted to define MetS by adjusting to the visceral fat area 100cm2 in abdominal CT imaging4, 6, 7). Then, WC was adopted in National Cholesterol Education Program- the third revision of the Adult Treatment Panel (NCEP-ATP III) criteria8) and international diabetic federation (IDF)9). The concept of MS has been useful and seemed to contribute to the promotion of health of people worldwide for the past thirty years. However, arguments about the meaning of MetS have been raised10, 11). Prospective studies on MetS for cardiovascular events did not necessarily show positive results12).
The target organ disease of MetS is cardiovascular disease, so-called arteriosclerosis. CAVI has nearly been established as an index of arterial stiffness reflecting arteriosclerosis and is related to metabolic disorders13, 14). However, there are several reports that CAVI is not necessarily high in MetS15-18). Why were those contradictory data obtained?
There existed “obesity paradox about CAVI.” CAVI was negatively related to body mass index (BMI)19), and sometimes to WC20). However, CAVI positively related to visceral fat area index20). Park et al reported that CAVI was positively related to visceral fat area and pericardial fat and negatively related to subcutaneous adipose tissue21). A reason why MetS is not necessarily related to the incidence of cardiovascular events and did not show high CAVI might be due to the definition of MetS itself using WC for visceral fat tissue mass.
Recently, ABSI was proposed by Krakauer et al.22). As stated first, Kim et.al reported that MetS diagnosed with a body shape index (ABSI) instead of WC was more significantly associated with CAVI in all age–sex groups in Koreans. Nagayama also reported that ABSI was much more related with CAVI than WC or BMI in Japanese urban residents23). Sugiura also reported the same results in Japanese labor as stated above20).
Nagayama recently studied the differences in age-adjusted CAVI between MetS and non-MetS subjects diagnosed by various MetS criteria using WC or ABSI among Japanese urban residents2). Age-adjusted CAVI did not differ significantly between MetS subjects using WC and non-MetS subjects according to the criteria of the Japanese Committee7) and NCEP-ATPIII8). In contrast, age-adjusted CAVI was clearly higher in MetS subjects using ABSI than it was in non-MetS subjects according to both criteria. For IDF criteria only9), MetS subjects had higher age-adjusted CAVI than non-MetS subjects did when MetS was defined using either WC or ABSI.
As for a longitudinal study on renal function decline, Kaplan–Meier analysis over 4 years showed a much more remarkable decrease rate in subjects with MetS using ABSI than it did in those without it; however, almost no difference between subjects with and without MetS using WC was found24).
The body shape is different between races, and the meaning of various obesity indices might differ in each race. However, the coincidence between the studies from Korean and Japanese might indicate that the definition of MetS must be reconsidered as for the index of visceral adipose tissue mass. In the adoption of ABSI to the definition of MetS in place of WC might be recommended at least in Asian peoples.
In summary, Kim’s paper supported the idea that ABSI might be suitable in place of WC for the definition of MetS in terms of CAVI. The definition of MetS might be better reconsidered for Asian peoples. Further studies are required to clarify this problem.
Conflict of Interest
I have nothing to declare.
References
- 1) Kim S, Choi SY, Lee H, Kim JJ, Park HE. Sex and Age Differences in the Impact of Metabolic Syndrome and Its Components including A Body Shape Index on Arterial Stiffness in the General Population. J Atheroscler Thromb, 2022; 29: 1774-1790
- 2) Nagayama D, Watanabe Y, Yamaguchi T, Suzuki K, Saiki A, Fujishiro K, Shirai K. Issue of Waist Circumference for the Diagnosis of Metabolic Syndrome Regarding Arterial Stiffness: Possible Utility of a Body Shape Index in MiddleAged Nonobese Japanese Urban Residents Receiving Health Screening. Obes Facts, 2022; 15: 160-169. DOI: 10.1159/000520418
- 3) Sugiura T, Dohi Y, Takagi Y, Yokoch T, Yoshikane N, Suzuki K, TomiishiT, Takashi Nagami T, Iwase M, Takase H, Seo Y, Ohte N. A body shape index could serve to identify individuals with metabolic syndrome and increased arterial stiffness in the middle-aged population. Clin Nutr ESPEN, 2021 Dec; 46: 251-258. doi: 10.1016/j.clnesp.2021.10.001. Epub 2021
- 4) Matsuzawa Y, Funahashi T, Nakamura T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb, 2011; 18: 629-639
- 5) Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. Novel technique for the determination of body fat by computed tomography. Int J Obes, 1983; 7: 437-445
- 6) Nakamura T, Tokunaga K, Shimomura I, Nishida M, Yoshida S, Kotani K, Islam AH, Keno Y, Kobatake T, Nagai Y. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis, 1994; 107: 239-246
- 7) The Examination Committee of Criteria for Metabolic Syndrome. Definition and criteria of metabolic syndrome. J Jpn Soc Int Med, 2005; 94: 794-809
- 8) National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment on High Blood Cholesterol in Adults (Adults Treatment Panel Ⅲ). Third Report on the National Cholesterol Education Pro- gram (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) final report. Circulation, 2002; 106: 3143-3421
- 9) Alberti KG, Zimmet P, Shaw. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. J. Diabet Med., 2006; 23: 469-480
- 10) Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr, 2006; 83: 1237-1247
- 11) Grundy SM. Does a diagnosis of metabolic syndrome have value in clinical practice. Am J Clin Nutr, 2006; 83: 1248-1251
- 12) Sundström J, Vallhagen E, Risérus U, Byberg L, Zethelius B, Berne C, Lind L, Ingelsson E. Risk associated with the metabolic syndrome versus the sum of its individual components. Diabetes Care, 2006; 29: 1673-1674
- 13) Liu H, Zhang X, Feng X, Li J, Hu M, Yambe. Effects of metabolic syndrome on cardio-ankle vascular index in middle-aged and elderly Chinese. Metab Syndr Relat Disord, 2011. PMID: 21091187
- 14) Saiki A, Ohira M, Yamaguchi T, Nagayama D, Shimizu N, Shirai K, Tatsuno I. New Horizons of Arterial Stiffness Developed Using Cardio-Ankle Vascular Index (CAVI). J Atheroscler Thromb, 2020; 27: 732-748
- 15) Topouchian J, Labat C, Gautier S, Bäck M, Achimastos A, Blacher J, Cwynar M, de la Sierra A, Pall D, Fantin F, Farkas K, Garcia-Ortiz L, Hakobyan Z, Jankowski P, Jelakovic A, Kobalava Z, Konradi A, Kotovskaya Y, Kotsani M, Lazareva I, Litvin A, Milyagin V, Mintale I, Persson O, Ramos R, Rogoza A, Ryliskyte L, Scuteri A, Sirenko Y, Soulis G, Tasic N, Udovychenko M, Urazalina S, Wohlfahrt P, Zelveian P, Benetos A, Asmar R. Effects of metabolic syndrome on arterial function in different age groups: the Advanced Approach to Arterial Stiffness study. J Hypertens, 2018. PMID: 29324585,
- 16) Garcia-Ortiz L, Patino-Alonso M, Leticia J, Gomez S, Recio-Rodriguez A, Fernando R, Marti R, Agudo-Conde C, Rodriguez-Sanchez E, Maderuelo-Fernandez J, Ramos R, Gomez-Marcos M, MARK Group. Association of metabolic syndrome and its components with arterial stiffness in Caucasian subjects of the MARK study: a cross-sectional trial. Cardiovasc Diabetol, 2016; 15(1): 148
- 17) Nam S-H, Kang S-G, Lee Y-A, Song S-W, Rho J-H. Association of Metabolic Syndrome with the Cardioankle Vascular Index in Asymptomatic Korean Population. J Diabetes Res, 2015. PMID: 26273666 Free PMC article.
- 18) Satoh N, Shimatsu A, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Ooishi M, Kotani K, Ogawa Y. Evaluation of the cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obesity and metabolic syndrome. Hypertens Res, 2008; 31: 1921-1930
- 19) Nagayama D, Imamura H, Sato Y, Yamaguchi T, Ban N, Kawana H, Ohira M, Saiki A, Shirai K, Tatsuno I. Inverse relationship of cardioankle vascular index with BMI in healthy Japanese subjects: a cross-sectional study. Vasc Health Risk Manag, 2016; 13: 1-9
- 20) Sugiura T, Dohi Y, Takagi Y, Yoshikane N, Ito M, Suzuki K, Nagami T, Iwase M, Seo Y, Ohte N. Relationships of obesity-related indices and metabolic syndrome with subclinical atherosclerosis in middle-aged untreated Japanese workers. J Atheroscler Thromb, 2020; 27: 342-352
- 21) Park HE, Choi SY, Kim HS, Kim MK, Cho SH, Oh BH. Epicardial fat reflects arterial stiffness: assessment using 256-slice multidetector coronary computed tomography and cardio-ankle vascular index. J Atheroscler Thromb, 2012; 19: 570-576
- 22) Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS One, 2012; 7: e39504
- 23) Nagayama D, Watanabe Y, Yamaguchi T, Maruyama M, Saiki A, Shirai K, Tatsuno I. New index of abdominal obesity, a body shape index, is BMI-independently associated with systemic arterial stiffness in real-world Japanese population. Int J Clin Pharmacol Ther, 2020; 58: 709-717
- 24) Nagayama D, Fujishiro K, Tsuda K, Watanabe Y, Yamaguchi T, Suzuki K, Saiki A, andi Shirai K. Enhanced prediction of renal function decline by replacing waist circumference with “A Body Shape Index (ABSI)” in diagnosing metabolic syndrome: a retrospective cohort study in Japan. Int J Obes, 2022; 46: 564-557